dc.creatorKonttinen, Yrjö T.
dc.creatorAzuma, M.
dc.creatorGonzález Burgos, María Julieta
dc.creatorCovarrubias, Sergio Aguilera
dc.creatorCastillo, Claudio Molina
dc.creatorCampos, Lisette Leyton
dc.date.accessioned2019-01-29T14:13:55Z
dc.date.available2019-01-29T14:13:55Z
dc.date.created2019-01-29T14:13:55Z
dc.date.issued2004
dc.identifierArthritis and Rheumatism, Volumen 50, Issue 7, 2018, Pages 2374-2376
dc.identifier00043591
dc.identifier10.1002/art.20307
dc.identifierhttps://repositorio.uchile.cl/handle/2250/160258
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceArthritis and Rheumatism
dc.subjectImmunology and Allergy
dc.subjectRheumatology
dc.subjectImmunology
dc.subjectPharmacology (medical)
dc.titleMatrix metalloproteinase 9 in the saliva of patients with Sjögren's syndrome: Comment on the article by Goicovich et al [2] (multiple letters)
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución